How to treat colds in innovation Chinese medicine

Source: Star of Securities

Recently, the "2021 ~ 2022 China Family Standing Medicine Brand" selection activity jointly created by the family doctor online and the new generation of market monitoring agencies, after several months of channel declaration, market research, expert review, popularity, list of lists, lists, lists After publicity and other links, it was grandly announced. With Lingye Pharmaceutical Lianhua Qing Plague Capsules, the "Chinese Family Standing Medicine (Cold Medicine) Brand" was listed on the list for six consecutive years.

Colds are common and multi -disease in life. Fluid is a major infectious disease that threatens human beings, and the new crown and flu have the same ways of spreading -based on the respiratory tract. Today, in the normalization of the epidemic prevention and control Respiratory diseases are the primary precautions for most families' health. As a representative drug of Chinese medicine cold medicine, cure for colds and anti -influenza has become a standing medicine in Chinese home medicine boxes.

It is an innovative Chinese medicine developed under the guidance of the Chinese Medicine Listing theory. It draws the essence of the famous medicine of the Han, Ming, and Qing dynasties to treat colds and influenza. Based on the Basic Foundation of Warm Diseases, Yin Qiao San is the basis of the Ming Dynasty Wu and the experience of treating rhubarb for the treatment of epidemic diseases in the Ming Dynasty. Improving immunity and righteousness, has good fever, cough, anti -inflammatory, and antiviral effects.

Since its launch in 2005, even the flowers Qing Plagas have been included in the new crown pneumonia, A, flow, and bird flu in the National Health and Health Commission and the State Administration of Traditional Chinese Medicine. It has become a representative proprietary Chinese medicine for public health incidents in respiratory virus infectious public health incidents, which are included in the national medical insurance directory and basic medicine directory.

The safety and effectiveness of Lianhua Qingjuan for cold flu and the prevention and control of new crown pneumonia have been confirmed by many domestic scientific research institutes. For ordinary colds, research institutes from the Chinese Academy of Traditional Chinese Medicine Respiratory hypotomyosis, adsorb flu virus, rhinovirus, adenovirus, and herpes zosperthyll virus all have inhibitory effects; in terms of flu, the basic studies of the Institute of Highness Diseases of the Guangzhou Respiratory Diseases and the Chinese Academy of Chinese Medical Sciences have confirmed that even flowers Qing Plague It can obviously inhibit various influenza viruses such as H1N1, H3N2), avian influenza, and type B virus; in terms of the new crown virus, even the flowers of the flowers are effective drugs for the treatment of new crown pneumonia. , Treatment and reduction of the three major advantages of rotating diseases, and have obtained the foundation and clinical research of many domestic research institutes, which have confirmed the "New Coronary Virus Pneumonia Diagnosis and Treatment Plan" jointly released by the State Health and Health Commission and the State Administration of Traditional Chinese Medicine (trial Fourth/five/six/seven/eight/ninth editions) and more than 20 provinces and cities are recommended.

According to Zhongkang Information data, the size of cold medication/clearing heat market in the first half of 2022 in the retail pharmacy is approximately 14.6 billion, and the market share of the flowers Qingjuan products increased from 2.44%to 9.37%in the first half of 2022. /The sales of heat -clearing sales ranked first, and have become the head brands for colds for colds in the retail market. At present, Lianhua Qingjuan has formed a large -scale sales in more than 100,000 medical terminals across the country, and more than 300,000 pharmacy terminals have formed large -scale sales, and have been recognized by the majority of clinicians and patients.

- END -